Chief Operating Officer, Takeda Pharmaceutical Company Limited
With more than 30 presentations given over two days, leaders in biopharmaceutical production will explore the latest technologies and manufacturing strategies for next-generation biologics and advanced therapies. This meeting focuses on key challenges within the field, evaluating innovative solutions such as continuous bioprocessing, SUTs, data integrity, PAT and the implementation of industry 4.0, all of which aim to increase the efficiency and yield of therapeutic production whilst maintaining high-quality standards. Once again, this meeting will also feature a track dedicated to the manufacturing of cell and gene therapies, exploring both the regulatory and manufacturing challenges of these complex products.
2019 Featured speakers – meet all the speakers here
The 2020 speaker panel will be assembled from leaders in biopharmaceutical production and will ensure that you walk away with an increased understanding of novel manufacturing techniques and technologies. Last year’s presentations focused on the following key learning objectives:
Days 1 and 2, Track 1 – Next-Generation Technologies & Novel Manufacturing Strategies
Panel Discussion: Industry 4.0: Challenges and Implementation
Day 1, Track 2, Quality Control, Analytics & the Regulatory Landscape
Day 2, Track 2 – Manufacturing Cell & Gene Therapies